Maulik P. Purohit, M.D., M.P.H., is the Chief Health Information Officer at the Lehigh Valley Health Network. He believes that "AI will enhance the patient experience" in 2024.
We asked our readers and some members of our editorial advisory board to make predictions for 2024. Here's what Maulik P. Purohit, M.D., M.P.H., had to say:
“Artificial intelligence (AI) is taking the healthcare industry by storm, extending beyond just corporate services such as finance and operations. From onboarding to documentation, AI is revolutionizing the clinical experience for patients and clinicians, and this trend will continue in 2024. Credentialing that once took weeks can now be done in 15 minutes, making healthcare more accessible. Scheduling appointments is as easy as booking a flight, increasing the convenience. Clinical decision support systems are improving daily, hence improving patient safety and lowering costs. AI can handle menial tasks like documentation, allowing clinicians more time with their patients. AI will increasingly streamline nonclinical operations, translating into an enhanced patient clinical experience. Leveraging AI will finally bring back the care in healthcare and achieve true value-based care, brightening the future of healthcare.”
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
A Motor Neuron Mystery Points to New Potential SMA Treatment Targets
December 20th 2024Some muscles are resistant to the loss of motor neurons seen in patients with spinal muscular atrophy, and new research has discovered that even in muscles that appeared resistant to SMA, subtle changes had occurred at the cellular level.
Read More